Propranolol transiently inhibits reinstatement of nicotine-seeking behaviour in rats

Journal of Psychopharmacology

Volumn 24, Issue 3, 2010, Pages 389-395

  Chiamulera, C ^a   Tedesco, V ^a   Zangrandi, L ^a   Giuliano, C ^a   Fumagalli, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Addiction; Nicotine; Propranolol; Rat; Reinstatement; Relapse

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NICOTINE; NORADRENALIN; PROPRANOLOL; NICOTINIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTICLE; ASSOCIATION; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE COMPARISON; FOOD INTAKE; HYPERACTIVITY; INHIBITION KINETICS; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; REINFORCEMENT; RELAPSE; SMOKING CESSATION; TOBACCO DEPENDENCE; ADDICTION; ANIMAL; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEEDING BEHAVIOR; RECURRENT DISEASE; REWARD; SMOKING; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BEHAVIOR, ADDICTIVE; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; FEEDING BEHAVIOR; MALE; NICOTINE; NICOTINIC AGONISTS; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; REWARD; SELF ADMINISTRATION; SMOKING;

EID: 77950976519     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108097718     Document Type: Article

References (41)

1. Aston-Jones, G, Harris, GC (2004) Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47: 167-179. (Pubitemid 39298262)
2. Benwell, ME, Balfour, DJ (1997) Regional variation in the effects of nicotine on catecholamine overflow in rat brain. Eur J Pharmacol 325: 13-20.
3. Bernardi, RE, Lattal, KM, Berger, SP (2006) Postretrieval propranolol disrupts a cocaine conditioned place preference. Neuroreport 17: 1443-1447.
4. Bianchetti, G, Elghozi, JL, Gomeni, R, Meyer, P, Morselli, PL (1980) Kinetic of distribution of di-propranolol in various organs and discrete brain areas of the rat. J Pharmacol Exp Ther 214: 682-687. (Pubitemid 10061419)
5. Booze, RM, Crisostomo, EA, Davis, JN (1989) Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig. J Pharmacol Exp Ther 249: 911-920.
6. Borchard, U (1990) Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance. Clin Physiol Biochem 8: 28-34.
7. Buczek, Y, Lê, AD, Wang, A, Stewart, J, Shaham, Y (1997) Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology 144: 183-188. (Pubitemid 29264435)
8. Cardinal, RN, Parkinson, JA, Hall, J, Everitt, BJ (2002) Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26: 321-352. (Pubitemid 34555410)
9. Chiamulera, C, Borgo, C, Falchetto, S, Valerio, E, Tessari, M (1996) Nicotine reinstatement of nicotine self-administration after longterm extinction. Psychopharmacology 127: 102-107. (Pubitemid 26298006)
10. Cooper, BR, Wang, CM, Cox, RF, Norton, R, Shea, V, Ferris, RM (1994) Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 11: 133-141. (Pubitemid 24334069)
11. da Costa, CL, Younes, RN, Lourenco, MT (2002) Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo. Chest 122: 403-408.
12. Fu, Y, Matta, SG, Brower, VG, Sharp, BM (2001) Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: an in vivo microdialysis study. J Neurosci 21: 8979-8989. (Pubitemid 33054859)
13. Fu, Y, Matta, SG, James, TJ, Sharp, BM (1998) Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors. J Pharmacol Exp Ther 284: 1188-1196.
14. Fu, Y, Matta, SG, Kane, VB, Sharp, BM (2003) Norepinephrine release in amygdala of rats during chronic nicotine selfadministration: an in vivo microdialysis study. Neuropharmacology 45: 514-523. (Pubitemid 36936984)
15. Hahn, B, Stolerman, IP (2005) Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists. Psychopharmacology 177: 438-447. (Pubitemid 40228290)
16. Harris, GC, Aston-Jones, G (1993) Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology 113: 131-136. (Pubitemid 23341057)
17. Kampman, KM, Alterman, AI, Volpicelli, JR, Maany, I, Muller, ES, Luce, DD, et al. (2001a) Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav 15: 52-59. (Pubitemid 32194940)
18. Kampman, KM, Dackis, C, Lynch, KG, Pettinati, H, Tirado, C, Gariti, P, et al. (2006) A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend 85: 129-137.
19. Kampman, KM, Rukstalis, M, Ehrman, R, McGinnis, DE, Gariti, P, Volpicelli, JR, et al. (1999) Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence. Addict Behav 24: 287-291.
20. Kampman, KM, Volpicelli, JR, Mulvaney, F, Alterman, AI, Cornish, J, Gariti, P, et al. (2001b) Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend 63: 69-78.
21. Kim, HK, Hong, JH, Park, MS, Kang, JS, Lee, MH (2001) Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection. Biomed Chromatogr 15: 539-545.
22. Klimek, V, Zhu,MY, Dilley, G, Konick, L, Overholser, JC, Meltzer, HY, et al. (2001) Effects of long-term cigarette smoking on the human locus coeruleus. Arch Gen Psychiatry 58: 821-827.
23. Le Foll, B, Goldberg, SR (2005) Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. Trends Pharmacol Sci 26: 287-293.
24. Le Foll, B, Goldberg, SR (2006) Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology 184: 367-381.
25. Lee, JL, Milton, AL, Everitt, BJ (2006) Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. J Neurosci 26: 5881-5887.
26. Leri, F, Flores, J, Rodaros, D, Stewart, J (2002) Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22: 5713-5718.
27. Lerman, C, LeSage, MG, Perkins, KA, O'Malley, SS, Siegel, SJ, Benowitz, NL, et al. (2007) Translational research in medication development for nicotine dependence. Nat Rev Drug Discov 6(9): 746-762.
28. Matta, SG, Balfour, DJ, Benowitz, NL, Boyd, RT, Buccafusco, JJ, Caggiula, AR, et al. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190: 269-319.
29. Moore, RY, Bloom, FE (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 2: 113-168.
30. Rainbow, TC, Parsons, B, Wolfe, BB (1984) Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain. Proc Natl Acad Sci U S A 81: 1585-1589.
31. Sara, SJ (2000) Retrieval and reconsolidation: toward a neurobiology of remembering. Learn Mem 7: 73-84.
32. Shaham, Y, Adamson, LK, Grocki, S, Corrigall, WA (1997) Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology 130: 396-403.
33. Shaham, Y, Shalev, U, Lu, L, De Wit, H, Stewart, J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168: 3-20.
34. Shalev, U, Grimm, JW, Shaham, Y (2003) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1-42.
35. Shand, DG, Rangno, RE, Evans, GH (1972) The disposition of propranolol. II. Hepatic elimination in the rat. Pharmacology 8: 344-352.
36. Sharp, BM, Matta, SG (1993) Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization. Endocrinology 133: 11-19.
37. Sofuoglu, M, Kosten, TR (2005) Novel approaches to the treatment of cocaine addiction. CNS Drugs 19: 13-25. (Pubitemid 40165154)
38. Summers, KL, Giacobini, E (1995) Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res 20: 753-759.
39. Taylor, F, Cahill, L (2002) Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: a case study. J Trauma Stress 15: 433-437.
40. Vezina, P, McGehee, DS, Green, WN (2007) Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsychopharmacol Biol Psychiatry 31: 1625-1638. (Pubitemid 47625708)
41. Weinshenker, D, Schroeder, JP (2006) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32: 1433-1451. (Pubitemid 46920149)